Table 2.
Data collection forms | Sociodemographic | |
Dietary | 24-hour recall | |
Women’s Health Questionnaire | Health status* | |
Reproductive history | ||
Risk factors for NTDs | ||
Anthropometry | Circumference | Waist and hip |
Mid-upper arm | ||
Skinfolds | Triceps | |
Biological samples | Blood, saliva and urine |
Biomarker assessment | Indicator | Definition |
Complete blood count | Haemoglobin and anaemia | Hb <12.0 g/dL, <8.0 g/dL |
Erythrocyte (RBC) folate† | Folate status | RBC folate <305 nmol/L, <748 nmol/L |
Serum folate† | Serum folate <7.0 nmol/L | |
Total vitamin B12 | Vitamin B12 status | Vitamin B12 <148 pmol/L, <221 pmol/L |
*Morbidity, signs and symptoms.
†WHO-recommended microbiological assay.
NTDs, neural tube defects; RBC, red blood cell.